| Literature DB >> 35159911 |
Else Holmfred1,2, Jens J Sloth2, Katrin Loeschner2, Keld Alstrup Jensen1.
Abstract
Dissolution plays an important role on pulmonary toxicity of nanomaterials (NMs). The influence of contextual parameters on the results from dissolution testing needs to be identified to improve the generation of relevant and comparable data. This study investigated how pre-dispersions made in water, low-calcium Gamble's solution, phagolysosomal simulant fluid (PSF), and 0.05% bovine serum albumin (BSA) affected the dissolution of the Al2O3 coating on poorly soluble TiO2 also coated with glycerine (NM-104) and rapidly dissolving uncoated (NM-110) and triethoxycaprylsilane-coated ZnO (NM-111) NMs. Dissolution tests were undertaken and controlled in a stirred batch reactor using low-calcium Gamble's solution and phagolysosomal simulant fluid a surrogate for the lung-lining and macrophage phagolysosomal fluid, respectively. Pre-dispersion in 0.05% BSA-water showed a significant delay or decrease in the dissolution of Al2O3 after testing in both low-calcium Gamble's solution and PSF. Furthermore, use of the 0.05% BSA pre-dispersion medium influenced the dissolution of ZnO (NM-110) in PSF and ZnO (NM-111) in low-calcium Gamble's solution and PSF. We hypothesize that BSA forms a protective coating on the particles, which delays or lowers the short-term dissolution of the materials used in this study. Consequently, the type of pre-dispersion medium can affect the results in short-term dissolution testing.Entities:
Keywords: ICP-MS; biosimulant fluids; dissolution; nanomaterials; pre-dispersion
Year: 2022 PMID: 35159911 PMCID: PMC8840498 DOI: 10.3390/nano12030566
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Physicochemical characteristics of the test materials.
| Characteristics | NM-104 | NM-110 | NM-111 |
|---|---|---|---|
| Primary particle size ECD * (nm) | 25.0 ± 1.7 a | 75.4 ± 58.4 b | 40.6 c |
| Average aggregate size ECD * (nm) | 58.5 ± 46.3 a | 114 ± 97 d | 106 ± 69 d |
| Crystallite size by XRD (nm) | 27 e | 42 f | 24–42 f |
| Specific surface area (m2/g) | 56.8 ± 0.5 e | 12.4 ± 0.6 d | 15.1 ± 0.6 d |
| Material | TiO2—Rutile e | ZnO—Zincite f | ZnO—Zincite e |
| Inorganic coating (wt.%) | 6.08 Al2O3 g | None f | None e |
| Organic coating (wt.%) | 3.17 ± 0.07 h glycerine h | ND f | 2.1 ± 0.31 g triethoxycaprylsilane h |
| Moisture content (wt.%) | 1.50 ± 0.10 g | 0.28 ± 0.11 g | ND g |
* ECD: Equivalent Circular Diameter, obtained by EDS on sample pellet; ND: not detected. a De Temmerman et al. (2012), NANOGENOTOX Deliverable 4.2 [23]. b OECD—Dossier on Zink Oxide (2015) [24]. c Llewellyn et al. (2021) [25]. d Da Silva et al. (2019) [17]. e Rasmussen et al. (2014) [26]. f Singh et al. (2011) [27]. g Holmfred et al. (2022) [6]. h Clausen et al. 2019 [20].
Composition of phagolysosomal simulant fluid (PSF). Adapted from Ref. [22], and low-calcium Gamble’s solution. Adapted from Ref. [21].
| Simulated Lung Fluid | Component | Chemical Formula | Concentration [mg/L] |
|---|---|---|---|
| Phagolysosomal simulant fluid (PSF) | Sodium phosphate dibasic anhydrous | Na2HPO4 | 142 |
| Sodium chloride | NaCl | 6650 | |
| Sodium sulphate anhydrous | Na2SO4 | 71 | |
| Calcium chloride dihydrate | CaCl2·2H2O | 29 | |
| Glycine | H2NCH2CO2H | 450 | |
| Potassium hydrogen phthalate | (1-(HO2C)-2-(CO2K)-C6H4) | 4085 | |
| Alkylbenzyldimethylammonium chloride | - | 50 | |
| Low-calcium Gamble’s solution | Sodium chloride | NaCl | 6600 |
| Sodium bicarbonate | NaHCO3 | 2703 | |
| Calcium chloride | CaCl2 | 22 | |
| Sodium phosphate dibasic dodecahydrate | Na2HPO4·12H2O | 358 | |
| Sodium sulphate anhydrous | Na2SO4 | 79 | |
| Magnesium chloride hexahydrate | MgCl·6H2O | 212 | |
| Glycine | H2NCH2CO2H | 118 | |
| Sodium citrate dihydrate | Na3C6H5O7 ·2H2O | 153 | |
| Sodium tartrate dihydrate | Na2C4H4O6 ·2H2O | 180 | |
| Sodium pyruvate | C3H3NaO3 | 172 | |
| Sodium lactate | C3H5NaO3 | 175 |
The following ICP-MS parameters were used to analyze the dissolved fractions of the TiO2 (NM-104) and ZnO (NM-110 and NM-111) in phagolysosomal fluid simulant (PSF) and low-calcium Gamble’s solution. The table presents the monitored isotopes related to the nanomaterial, the choice of internal standard, and the limit of detection.
| Parameters (Unit) | TiO2 | TiO2 | ZnO | ZnO |
|---|---|---|---|---|
| Nebulizer gas flow rate (L/min) | 0.89 | 1.06 | 1.02 | 1.04 |
| Auxiliary gas flow rate (L/min) | 0.80 | 0.80 | 0.80 | 0.80 |
| Helium cell gas flow rate (L/min) | 4.35 | 4.58 | No cell gas | No cell gas |
| Monitored isotopes ( | 27Al and 48Ti | 27Al and 48Ti | 64Zn | 64Zn |
| Internal standard ( | 103Rh | 103Rh | 103Rh | 103Rh |
| Limit of detection | Al: 19 µg/L, | Al: 22 µg/L, | 10 µg/L | 5.4 µg/L |
| Dilution factor for ICP-MS analysis | ×10 | ×4 | ×1000 | ×200 |
Bovine serum albumin adsorption to TiO2 (NM-104) (n = 4) and ZnO (NM-110 and NM-111) (n = 2).
| Particle Concentration | Sample | µg BSA/mg NM | Percent Adsorbed of the BSA Added | Literature Values | Literature Values |
|---|---|---|---|---|---|
| 2.56 | TiO2 (NM-104) | 131.8 ± 22.0 | 69 | 143.7 ± 12.9 # | 66 # |
| 2.56 | ZnO (NM-110) | 138.3 ± 18.4 | 67 | 151.8 ± 27.0 ⱡ | 69 ⱡ |
| 2.56 | ZnO (NM-111) | 88.3 ± 27.1 | 43 | 292.8 ± 41.5 ⱡ | 40 ⱡ |
# Guiot and Spalla (2013) [19]. ⱡ From Da Silva et al. (2019a) [17].
Z-average (Zave), zeta potential (Zpot), and polydispersity index (PDI) of ZnO (NM-110 and NM-111) and TiO2 (NM-104) in pre-dispersions made in water, phagolysosomal fluid simulant (PSF), and low-calcium Gamble’s solution. The values were compared to the literature average agglomeration size (Daggr) listed in Table 1 and benchmark Z-averages (Zave, benchmark). See supplementary (Figures S1–S3) for hydrodynamic size number distribution spectra (TiO2 (NM-104, S1, A-F), ZnO (NM-110, S2, A-F), and ZnO (NM-111, S3, A-F). The relative color range shown was made using the lowest (green) and highest (red) size ratio when compared with the Daggr and Zave,benchmark data.
| Test Medium | Nanomaterial | Dispersion | Zave [nm] | PDI | Zpot [mV] | Zave,benchmark | Zave/Daggr | Zave/Zave,benchmark |
|---|---|---|---|---|---|---|---|---|
| Low-calcium | TiO2 (NM-104) | Water | 157.8 ± 2.3 | 0.24 ± 0.01 | 14.9 ± 0.7 | 234 ± 4 a | 2.7 | 0.7 |
| GS | 2827 ± 1895 | 0.88 ± 0.3 | 14.9 + 0.7 | 48.3 | 12.1 | |||
| 0.05% BSA | 724.0 ± 160.2 | 0.74 ± 0.1 | −0.8 ± 1.0 | 12.4 | 3.1 | |||
| ZnO (NM-110) | Water | 225.3 ± 2.2 | 0.15 ± 0.02 | 30.7 ± 0.6 | 233.1 ± 7.3 b | 2.0 | 1.0 | |
| GS | 1824 ± 343 | 1.0 ± 0.0 | −16.2 ± 0.6 | 16.0 | 7.8 | |||
| 0.05% BSA | 250.6 ± 1.1 | 0.14 ± 0.02 | −13.4 ± 0.3 | 2.2 | 1.1 | |||
| ZnO (NM-111) | Water | 735.1 ± 97.0 | 0.37 ± 0.07 | 12.5 ± 0.5 | 247.4 ± 4.9 b | 6.9 | 3.0 | |
| GS | 3578 ± 303 | 0.31 ± 0.1 | −13.1 ± 1.0 | 33.8 | 14.5 | |||
| 0.05% BSA | 278.9 ± 2.9 | 0.16 ± 0.02 | −14.5 ± 0.5 | 2.6 | 1.1 | |||
| PSF | TiO2 (NM-104) | Water | 162.9 ± 1.9 | 0.24 ± 0.01 | 13.4 ± 0.5 | 234 ± 4 a | 2.8 | 0.7 |
| PSF | 3448 ± 2283 | 0.93 ± 0.2 | 0.6 ± 0.8 | 58.9 | 14.7 | |||
| 0.05% BSA | 366.7 ± 153.7 | 0.30 ± 0.09 | −1.3 ± 0.4 | 6.3 | 1.6 | |||
| ZnO (NM-110) | Water | 257.0 ± 1.6 | 0.16 ± 0.02 | 24.6 ± 0.6 | 233.1 ± 7.3 b | 2.3 | 1.1 | |
| PSF | 3989 ± 820 | 1.0 ± 0.0 | −15.0 ± 2.6 | 35.0 | 17.1 | |||
| 0.05% BSA | 247.1 ± 2.5 | 0.30 ± 0.09 | −14.6 ± 0.6 | 2.2 | 1.1 | |||
| ZnO (NM-111) | Water | 868.1 ± 118.5 | 0.35 ± 0.07 | 12.0 ± 0.3 | 247.4 ± 4.9 b | 8.2 | 3.5 | |
| PSF | 5410 ± 680 | 0.61 ± 0.06 | −13.4 ± 2.3 | 51.0 | 21.9 | |||
| 0.05% BSA | 275.9 ± 2.6 | 0.15 ± 0.02 | -16.7 ± 0.8 | 2.6 | 1.1 |
a From Jensen et al. [10]. b From Meija et al. [32].
Figure 1Dissolution profiles of the Al2O3 coating of TiO2 (NM-104) using the ATempH SBR system. (A) TiO2 (NM-104) dispersed in low-calcium Gamble’s solution (■), water (●), and 0.05% BSA (▲). (B) TiO2 (NM-104) dispersed in phagolysosomal simulant fluid (PSF) (■), water (●), and 0.05% BSA (▲). The dissolution tests were conducted for 24 h.
Figure 2Dissolution profiles of ZnO (NM-110). (A) ZnO (NM-110) dispersed in low-calcium Gamble’s solution (■), water (●), and 0.05% BSA (▲). (B) ZnO (NM-110) dispersed in phagolysosomal simulant fluid (PSF) (■), water (●), and 0.05% BSA (▲). The dissolution tests were conducted for 24 h. Note the differences in the y-axis scale.
Figure 3Dissolution profiles of ZnO (NM-111). (A) ZnO (NM-111) dispersed in low-calcium Gamble’s solution (■), water (●), and 0.05% BSA (▲). All dispersions were tested in low-calcium Gamble’s solution for 24 h. (B) ZnO (NM-111) dispersed in phagolysosomal simulant fluid (PSF) (■), water (●), and 0.05% BSA (▲). All dispersions were tested in PSF for 24 h. Note the differences in the y-axis scale.
p-values for interaction between type of dispersion medium and time (t0, t1, t2, t4, and t24) for dissolution testing conducted in low-calcium Gamble’s solution and PSF. A = 0.05 was used as level of significance (highlighted in bold).
| Interaction | TiO2 (NM-104) | ZnO (NM-110) | ZnO (NM-111) |
|---|---|---|---|
| Gamble’s solution vs. water | 0.5233 | 0.3792 | 0.2858 |
| Gamble’s solution vs. 0.05% BSA |
| 0.3534 |
|
| Water vs. 0.05% BSA |
| 0.3909 | 0.0711 |
| PSF vs. Water | 0.6167 | 0.5987 |
|
| PSF vs. 0.05% BSA |
|
|
|
| Water vs. 0.05% BSA |
|
|
|
Overview of the initial concentrations (S@ti) measured at t0 + 25 min (t=0.4 h), the initial dissolutions rate, and surface area dissolution rates, , determined from the batch reactor setup ND: not determined, quick dissolution. The results are presented as average values ± standard deviation (n = 3 batch reactors).
| Test Medium: Gamble’s Solution | Test Medium: PSF | ||||||
|---|---|---|---|---|---|---|---|
| Dispersion Medium | Dispersion Medium | ||||||
| Nanomaterial | Initial Concentration | Gamble’s Solution | Water | 0.05% BSA | PSF | Water | 0.05% BSA |
| TiO2 | S@ti (mg/L) | 0.097 ± 2.04 × 10−3 | 0.096 ± 7.94 × 10−3 | 0.092 ± 1.65 × 10−3 | 0.139 ± 2.39 × 10−3 | 0.0965 ± 2.91 × 10−3 | 0.069 ± 4.0 × 10−3 |
| 0.171 ± 0.064 | 0.126 ± 0.018 | 0.160 ± 0.038 | 0.230 ± 0.031 | 0.220 ± 0.014 | 0.096 ± 0.002 | ||
| 0.027 ± 0.010 | 0.020 ± 2.8 × 10−3 | 0.025 ± 5.92 × 10−3 | 0.036 ± 4.8 × 10−3 | 0.034 ± 2.26 × 10−3 | 0.015 ± 2.73 × 10−4 | ||
| ZnO | S@ti (mg/L) | 22.3 ± 2.5 | 16.4 ± 0.4 | 10.7 ± 0.5 | 116.3 ± 7.3 | 125.0 ± 0.9 | 108.1 ± 2.3 |
| 2.72 ± 2.59 | 0.720 ± 0.191 | 2.04 ± 0.22 | ND | ND | ND | ||
| 0.094 ± 0.089 | 0.025± 6.6 × 10−3 | 0.070 ± 7.74 × 10−3 | ND | ND | ND | ||
| ZnO | S@ti (mg/L) | 4.83 ± 0.27 | 5.76 ± 0.23 | 4.10 ± 0.61 | 112.1 ± 0.8 | 104.5 ± 3.8 | 74.67 ± 4.52 |
| 0.604 ± 0.582 | 2.09 ± 1.71 | 1.95 ± 0.26 | ND | ND | ND | ||
| 0.025 ± 0.024 | 0.088± 0.072 | 0.082 ± 0.011 | ND | ND | ND | ||